Glucose Uptake and Exercise (LOIL1) Flashcards

1
Q

what are the 3 questions about how we keep the human alive ?

A
  1. how to break down the nutrients and extract the energy to maintain cellular functions ?
  2. how to store the energy and maintain the cell structures ?
  3. how to transport the molecules in and out of there cell ?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what can move via passive diffusion ?

A
  1. small non-polar ions
  2. hydrophobic molecules (such as steroid hormones)
  3. water (to some degree)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are ‘Solute Carrier (SLC ) Transporters’ ?

A

the largest group of transporters classified into 65 different gene families with 458 different transporters in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SLC transport what 6 things?

A
  1. monosaccharides
  2. amino acids
  3. fatty acids
  4. vitamins
  5. neurotransmitters
  6. inorganic/metal ions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what can SLC inhibitors be used for ?

A

SLC inhibitors can be used as drugs for the treatment od diseases (eg - SLC5A2 for hyperglycaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

state what it is meant by the key term - symporter

A

a symporter is a transporter which co-transports molecules in the same direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

state what it is meant by the key term - antiporter

A

an antiporter is a transporter which co-transports molecules in opposite directions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

state 7 examples of SLC transporters

A
  1. facilitated transporter
  2. antiporter
  3. symporter
  4. orphan transport
  5. rocker switch
  6. gated pore
  7. elevator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

transporter kinetics law = ?

A

transporter kinetics law = enzymes kinetic laws

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the 2 kinetics laws you need to remember for transporters ?

A
  1. affinity of the transporter for its substrate = Km (Michaelis constant)
  2. velocity of the substrate across the CSM = Vmax (maximum rate of reaction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

state the 3 types of transport inhibition

A
  1. competitive
  2. non-competitive
  3. allosteric
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is glucose transported across cell membranes (2 ways)

A
  1. secondary active transport

2. facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the mode of glucose transport across a CSM depends upon what ?

A

depends upon the concentration of glucose within the interstitial fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

both modes of glucose transport are performed by SLC transporters, but from different families. state the 2 transporters used

A
  1. SLC2 family - facilitated diffusion

2. SLC5 family - secondary active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what family is the following transporter part of - sodium-glucose co-transporter (SGLT)

A

SLC5 family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

state the names of the 2 SGLT’s (sodium-glucose co-transporter)

A
  1. SGLT1

2. SGLT2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

state 3 facts about SGLT’s (sodium-glucose co-transporters)

A
  1. they require the electrochemical gradient of Na+ to transport glucose against its concentration gradient
  2. SGLT are secondary active transport transporters
  3. they require ATP (energy) and Na+/K+ ATPase in order to function
18
Q

state 1 fact about - ‘Sodium-Glucose Co-Transporter (SGLT) function’

A

they are exclusively present in tissues responsible for absorption/reabsorption of glucose from nutrients (small intestine SGLT1) or from urine (kidney SGLT2/SGLT1)

19
Q

state what it is meant by the key term - SGLT2 inhibitors

A

SGLT2 inhibitors are a new therapeutic drug for glucose control in people with diabetes (T2D and T1D)

20
Q

state the two families that the following transporter belongs to - ‘Facilitative Glucose Transporters (GLUT1) family’

A
  1. Solute Carrier Gene Family (SLC2a)

2. Major Facilitators Family (MFS) - which contains more than 500 members

21
Q

state the 5 types of class 1 Facilitative Glucose Transporters

A
  1. GLUT 1
  2. GLUT 2
  3. GLUT 3
  4. GLUT 4
  5. GLUT 14
22
Q

state the 4 types of class 2 Facilitative Glucose Transporters

A
  1. GLUT 5
  2. GLUT 7
  3. GLUT 9
  4. GLUT 11
23
Q

state the 5 types of class 3 Facilitative Glucose Transporters

A
  1. GLUT 6
  2. GLUT 8
  3. GLUT 10
  4. GLUT 12
  5. HMIT (GLUT 13)
24
Q

state the following for the GLUT transporter stated - GLUT 1

1) tissue
2) special feature
3) substrate specificity

A
  1. ubiquitous, red cells
  2. N/A
  3. glucose, galactose
25
state the following for the GLUT transporter stated - GLUT 14 1) tissue 2) special feature 3) substrate specificity
1. neurones 2. N/A 3. glucose, galactose
26
state the following for the GLUT transporter stated - GLUT 4 1) tissue 2) special feature 3) substrate specificity
1. fat, muscle 2. trafficking - regulated by insulin (LL motif) 3. glucose
27
state the following for the GLUT transporter stated - GLUT 2 1) tissue 2) special feature 3) substrate specificity
1. intestine, liver, kidney, Beta cell 2. mediates both uptake and efflux 3. glucose, galactose, fructose
28
state the following for the GLUT transporter stated - GLUT 5 1) tissue 2) special feature 3) substrate specificity
1. intestine, sperm 2. found primarily in fructose metabolising tissue 3. fructose, glucose
29
state the following for the GLUT transporter stated - GLUT 7 1) tissue 2) special feature 3) substrate specificity
1. intestine 2. apical membrane targeting 3. glucose, fructose
30
state the following for the GLUT transporter stated - GLUT 9a/9b 1) tissue 2) special feature 3) substrate specificity
1. kidney BLM 2. liver expression co-localises with GLUT2, but not kidney 3. glucose, fructose
31
state the following for the GLUT transporter stated - GLUT 11 1) tissue 2) special feature 3) substrate specificity
1. muscle, heart, fat, placenta, kidney, pancreas 2. 3 isoforms (A, B and C) 3. glucose, fructose
32
state the following for the GLUT transporter stated - GLUT 6/9 1) tissue 2) special feature 3) substrate specificity
1. brain, spleen 2. has LL targeting motif 3. glucose
33
state the following for the GLUT transporter stated - GLUT 8 1) tissue 2) special feature 3) substrate specificity
1. testes, fat, liver, brain, spleen 2. has LL targeting motif 3. glucose, fructose
34
state the following for the GLUT transporter stated - GLUT 10 1) tissue 2) special feature 3) substrate specificity
1, heart, lungs 2. N/A 3. glucose, galactose
35
state the following for the GLUT transporter stated - GLUT 12 1) tissue 2) special feature 3) substrate specificity
1. insulin-sensitive tissue 2. has LL targeting motif 3. glucose, fructose, galactose
36
state the following for the GLUT transporter stated - HMIT / GLUT 13 1) tissue 2) special feature 3) substrate specificity
1. brain 2. proton-coupled substrate movement 3. myoinositol (a type of sugar)
37
where is GLUT 4 mainly expressed ?
skeletal muscle, heart and adipose tissue
38
what is GLUT 4 ?
GLUT 4 is a highly specialised glucose transporter which is regulated by insulin and contraction
39
what was GLUT 4's original name ?
insulin-responsive glucose transporter (IRGT)
40
what does GLUT 4 do in response to insulin stimulation ?
GLUT 4 translocates/traffics to the CSM in response to insulin stimulation or muscle contraction
41
what does GLUT 4 also possess ?
GLUT 4 has a specialised intracellular storage compartment called - GLUT 4 Storage Compartment (GCS) - from there it is recruited to the CSM
42
what do deficits in insulin-stimulated GLUT 4 trafficking result in ?
deficits in insulin-stimulated GLUT 4 trafficking is an early manifestation to insulin resistance and the pre-diabetic phase of T2D